Trials / Completed
CompletedNCT00823407
Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- California Pacific Medical Center Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MDA | subjects will receive a single oral dose of MDA 98mg/70kg body weight |
| DRUG | Placebo | Subjects will receive a single oral dose of placebo |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-01-15
- Last updated
- 2013-05-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00823407. Inclusion in this directory is not an endorsement.